SUPERNUS PHARMACEUTICALS, INC. (SUPN) Insider Trading

Name: SUPERNUS PHARMACEUTICALS, INC. (SUPN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 14, 2026): Khattar Jack A. (President, CEO): Exercise/Conversion of 29,849 shares.

Get alerted when insiders trade SUPN

Email address

Loading company data...

Beta

Loading company details...

Beta